Efficacy and Safety of Fingolimod in Daily Practice: Experience of an Academic MS French Center

INTRODUCTION: Fingolimod (Fg), a sphingosine 1-phosphate receptor modulator, decreases the annual relapse rate (ARR) in relapsing-remitting multiple sclerosis (RRMS). The aim of this study was to assess the efficacy and safety of Fg in daily practice in patients with RRMS, previously treated with na...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Neurol
Main Authors: Roux, Thomas, Maillart, Elisabeth, Vidal, Jean-Sébastien, Tezenas du Montcel, Sophie, Lubetzki, Catherine, Papeix, Caroline
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2017
Assuntos:
Neuroscience
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5418224/
https://ncbi.nlm.nih.gov/pubmed/28529497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2017.00183
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares